BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1695006)

  • 21. Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo.
    Yang XP; Schaper F; Teubner A; Lammert F; Heinrich PC; Matern S; Siewert E
    J Hepatol; 2005 Oct; 43(4):704-10. PubMed ID: 16040151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response.
    Geiger T; Towbin H; Cosenti-Vargas A; Zingel O; Arnold J; Rordorf C; Glatt M; Vosbeck K
    Clin Exp Rheumatol; 1993; 11(5):515-22. PubMed ID: 8275587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
    Cahlin C; Körner A; Axelsson H; Wang W; Lundholm K; Svanberg E
    Cancer Res; 2000 Oct; 60(19):5488-93. PubMed ID: 11034092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the adrenals in the acute phase response to interleukin-1 and tumor necrosis factor-alpha.
    Gelin JL; Moldawer LL; Iresjö BM; Lundholm KG
    J Surg Res; 1993 Jan; 54(1):70-8. PubMed ID: 8429642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response.
    Espat NJ; Auffenberg T; Rosenberg JJ; Rogy M; Martin D; Fang CH; Hasselgren PO; Copeland EM; Moldawer LL
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R185-90. PubMed ID: 8760219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis.
    Kozak W; Poli V; Soszynski D; Conn CA; Leon LR; Kluger MJ
    Am J Physiol; 1997 Feb; 272(2 Pt 2):R621-30. PubMed ID: 9124487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The modulatory role played by TNF-alpha and IL-1 beta in the inflammatory responses induced by carrageenan in the mouse model of pleurisy.
    Fröde TS; Souza GE; Calixto JB
    Cytokine; 2001 Feb; 13(3):162-8. PubMed ID: 11161459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of IL-1 receptor antagonist and monoclonal anti-IL-1 receptor antibody to inhibit antigen-specific immune responses in vivo.
    Faherty DA; Claudy V; Plocinski JM; Kaffka K; Kilian P; Thompson RC; Benjamin WR
    J Immunol; 1992 Feb; 148(3):766-71. PubMed ID: 1530956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
    Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models.
    Sherry BA; Gelin J; Fong Y; Marano M; Wei H; Cerami A; Lowry SF; Lundholm KG; Moldawer LL
    FASEB J; 1989 Jun; 3(8):1956-62. PubMed ID: 2721856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin.
    Bopst M; Haas C; Car B; Eugster HP
    Eur J Immunol; 1998 Dec; 28(12):4130-7. PubMed ID: 9862349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1 beta.
    Ogimoto K; Harris MK; Wisse BE
    Endocrinology; 2006 Sep; 147(9):4445-53. PubMed ID: 16777969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice.
    Fantuzzi G; Ku G; Harding MW; Livingston DJ; Sipe JD; Kuida K; Flavell RA; Dinarello CA
    J Immunol; 1997 Feb; 158(4):1818-24. PubMed ID: 9029121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating interleukin 1 and tumor necrosis factor during inflammation.
    Moldawer LL; Gelin J; Scherstén T; Lundholm KG
    Am J Physiol; 1987 Dec; 253(6 Pt 2):R922-8. PubMed ID: 3501249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs.
    Yamashita K; Fujinaga T; Miyamoto T; Hagio M; Izumisawa Y; Kotani T
    J Vet Med Sci; 1994 Jun; 56(3):487-92. PubMed ID: 7524694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic gene expression and cytokine responses to sterile inflammation: comparison with cecal ligation and puncture sepsis in the rat.
    Bazel S; Andrejko KM; Chen J; Deutschman CS
    Shock; 1999 May; 11(5):347-55. PubMed ID: 10353541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis.
    Di Santo E; Sironi M; Pozzi P; Gnocchi P; Isetta AM; Delvaux A; Goldman M; Marchant A; Ghezzi P
    Neuroimmunomodulation; 1995; 2(3):149-54. PubMed ID: 8646564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological and cytokine responses in IL-1 beta-deficient mice after zymosan-induced inflammation.
    Fantuzzi G; Sacco S; Ghezzi P; Dinarello CA
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R400-6. PubMed ID: 9249578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.
    Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD
    Infect Immun; 2001 Oct; 69(10):6445-55. PubMed ID: 11553589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.